Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes
暂无分享,去创建一个
W. Jusko | C. Mathieu | G. Hale | L. Chatenoud | H. Waldmann | P. Wiczling | Annette-G Ziegler | B. Keymeulen | Emma Bolam | E. Vandemeulebroucke | P. Rebello | I. Bakir | Emma J Bolam | Annette‐G Ziegler